“Safety and effectiveness of new embolization microspheres SCBRM for intermediate-stage hepatocellular carcinoma: A feasibility study” (2021) Biomolecules and Biomedicine, 21(3), pp. 339–345. doi:10.17305/bjbms.2020.4770.